Recommendations include use of ACE-I or ARB to slow CKD progression in patients with hypertension and albuminuria.

Study results are based on Surveillance, Epidemiology, and End Results-Medicare data for 166,581 patients receiving surgery or radiation for localized prostate cancer.

Comparable and high THC-to-CBD ratio products may result in small improvements in pain and increase in common adverse events.

Lower number of hospitalizations for any indication and serious adverse events with semaglutide for those with CVD, overweight or obesity.

Investigators compared the risk of cancer onset in patients with lupus nephritis treatedwith calcineurin inhibitors vs ...

The number and frequency of intravesical instillations for non-muscle-invasive bladder cancer (NMIBC) impairs quality of life and needs to be reported in clinical trials.

Atacicept, a novel dual inhibitor of BAFF and APRIL, receives FDA Priority Review for IgA nephropathy treatment in adults.

Investigators sought to evaluate changes in the estimated CV risk of men with prostate cancer after 6 months of hormone therapy using clinical tools established for the general population. A post-hoc ...

(HealthDay News) — Chronic kidney disease (CKD) reduces quality of life (QoL) for patients and their caregivers globally, according to a study published online Dec. 24 in Advances in Therapy.

When cancer subtypes were examined, the analysis revealed that phototherapy was linked to a 40% increased odds of blood cancers. More modest associations were observed for solid organ cancers and ...

Researchers reported on patient acceptance of an e-consent tool for asynchronous delivery of study information and for receiving consent from patients.